Abstract
Unexpected increase of Hepatitis B Surface Antigen (HBsAg) levels during treatment with nucleos(t)ide analogous 12–24 months before virological breakthrough and resistance
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have